Advertisement

Topics

Latest "Distributed Bio, Inc." News Stories

23:25 EST 22nd February 2019 | BioPortfolio

Here are the most relevant search results for "Distributed Bio, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Distributed Bio, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Distributed Bio, Inc. for you to read. Along with our medical data and news we also list Distributed Bio, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Distributed Bio, Inc. Companies for you to search.

Showing "Distributed" News Articles 1–25 of 752

Friday 22nd February 2019

Fulton Seafood Inc. Recalls Siluriformes Products Produced Without Benefit of Inspection

Fulton Seafood INC., a Houston, Texas establishment, is recalling approximately 100,924 pounds of Siluriformes fish products, specifically wild caught catfish, because the products were produced, packed, and distributed without the benefit of federal inspection.


Novo Nordisk: Notice for the Annual General Meeting of Novo Nordisk A/S

Bagsværd, Denmark, 22 February 2019 - The Annual General Meeting of Novo Nordisk A/S will be held on:  - Thursday 21 March 2019 at 2.00 pm (CET) at Bella Center, Center Boulevard 5, DK-2300 Copenhagen S, Denmark. The notice for the Annual General Meeting is attached. BOARD OF DIRECTORS - PROPOSED CHANGES IN COMPOSITION All current board members elected by the Annual General...

Notice of Nexstim Plc 2018 Full Year Results

Company announcement, Helsinki, 22.02.2019 at 9am (EET)Notice of Nexstim Plc 2018 Full Year Results Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted neuromodulation company developing and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of Major Depression Disorder (MDD), will announce...


Xbrane Biopharma releases Year-end report for 2018

Press release2019-02-22  Xbrane Biopharma AB's (publ.) ("Xbrane") Year-end report for 2018 is now available on the Company's website, www.xbrane.com. The fourth quarter 2018 in summary Revenue amounted to SEK 4,896 thousand (9,535). Gross margin amounted to 25% (24). Other operating income amounted to SEK 1,

Thursday 21st February 2019

Split and continuous sleep in teens impact cognition and glucose levels differently

(Duke-NUS Medical School) Under conditions of insufficient sleep, effects on cognitive performance and morning glucose levels vary depending on how sleep is distributed, says study's principal investigator Professor Michael Chee.

Bavarian Nordic Announces Initiation of Phase 1/2a Clinical Trial of Therapeutic HPV Vaccine Regimen in Collaboration with Janssen

First commercial program under Bavarian Nordic and Janssen Vaccines & Prevention B.V. collaboration advancing into clinical trials A therapeutic vaccine may represent a novel approach for early treatment and interception of HPV-induced cancers COPENHAGEN, Denmark, February 21, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced that the first patient has been d...

Invitation - Inventiva's Full Year 2018 Financial Results publication

INVITATION Inventiva's Full Year 2018 Financial Results publication Wednesday, February 27, 2019 Inventiva's full year 2018 financial results will be releasedat 5:45 pm (Paris), 4:45 pm (London). They will be available at the same time on Inventiva's website: http://inventivapharma.com/fr/accueil/ The company would like to invite you to a conference call to presentits res...

Axilum Robotics Announces U.S. FDA 510(k) Clearance for TMS-Cobot

Built on the company's new collaborative robotic platform, TMS-Cobot TS MV aids in the precise implementation of Transcranial Magnetic Stimulation (TMS) Axilum Robotics, specializing in the development of medical robots, announces that, 2 weeks after the CE mark, the Company has received 510(k) clearance from the U.S. Food and Drug Administration to ma...

Xbrane Biopharma AB: Alessandro Sidoli and Saeid Esmaeilzadeh decline re-election for 2019

Press release2019-02-21  Xbrane Biopharma AB (publ) ("Xbrane") has today been informed by the Nomination Committee that Alessandro Sidoli and Saeid Esmaeilzadeh have declined re-election at the Annual General Meeting (AGM) 2019. The Nomination Committee is working to find replacements for the board members and information about any new board members will be published i...

Indivior launches generic version of its addiction drug Suboxone

Indivior launched a generic version of Suboxone, which will be marketed and distributed by Sandoz.  -More- 

SpineFrontier's® First SacroFUSE® and NanoFUSE Case Performed in Latin America

Dr. Cahueque First in Latin America to Implant SpineFrontier’s SacroFuse System and NanoFUSE’s Orthobiologic BEVERLY, Mass. (PRWEB) February 21, 2019 On January 7th, 2019, Neurosurgeons Dr. Mario Cahueque and Dr. Enrique Azmitia implanted SpineFrontier’s SacroFuse system in conjunction with NanoFUSE’s Orthobiologic during a surgery at the Hospital Centro Medico in Guatemala City, Guatemal...

Ossur Hf : Final agenda and proposals for the Annual General Meeting 7 March 2019

Announcement no. 12/201921 February 2019  Final agenda and proposals Enclosed is the final agenda and proposals for Össur's Annual General Meeting to be held on Thursday 7 March 2019. The meeting will be held at Össur's headquarters at Grjótháls 5, Reykjavik, Iceland. No changes have been made to the previously announced agenda and proposals. Further information David Hreidar...

Biocartis Group NV: BIOCARTIS TO HOST WEBCAST FOR ANNOUNCEMENT 2018 FINANCIAL RESULTS ON 28 FEBRUARY 2019

   PRESS RELEASE: REGULATED INFORMATION21 February 2019, 07:00 CET BioCARTIS to Host Webcast FOR ANNOUNCEMENT 2018 FINANCIAL Results on 28 FEBRUARY 2019 Mechelen, Belgium, 21 February 2019 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular diagnostics company, today announces that it will host a live webcast on Thursday 28 Februar...

Wednesday 20th February 2019

Study Demonstrates Cook Biotech's OASIS® Wound Matrix Has Higher Rates of Healing in Pressure Ulcers Than Standard of Care

A recently published multi-center, randomized, controlled trial (RCT) demonstrated higher rates of healing when using OASIS® Wound Matrix with standard of care (SOC) for the treatment of full-thickness Stage III or Stage IV pressure ulcers than when using SOC alone.1 Pressure ulcers are open wounds caused by pressure. They often occur when an ind...

Medtronic EVP & RTG President Geoff Martha to Speak at Leerink Partners Global Healthcare Conference

DUBLIN - February 20, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 8th Annual Leerink Partners Global Healthcare Conference in New York. Geoff Martha, executive vice president and president of the Restorative Therapies Group (RTG) of Medtronic, will make a brief presentation and answer questions on the company, b...

Xbrane Biopharma AB advances the release of the Year-end report for 2018

Press release2019-02-20 Xbrane Biopharma AB hereby announce that it has been decided to advance the publication of the Year-end report for the financial year of 2018. The Year-end report will be released on Friday 22 February, 2019 instead of Thursday 28 February, 2019 as previously stated. For further information, please contact:Martin Åmark, CEO/IRM: +46(0) 763-093 777E: mart...

Upwell Health Appoints Patrick Grosso as Chief Financial Officer

Former Skullcandy executive will lead financial strategy and help guide company’s transformational growth Upwell Health, a company that makes pharmacy the central point of care for people with chronic conditions, today announced that it has strengthened its leadership team with the appointment of Patrick Grosso as chief financial off...

ROKIT Healthcare Announces a Novel Application of Dermal Regeneration Platform Using Proprietary Three-Dimensional Bioprinting Strategy

Applications of the treatment will expand to different indications in need to regenerative therapeutic strategies, including scar removal, burns, and pressure/diabetic foot ulcers SEOUL, South Korea, Feb. 20, 2019 /PRNewswire/ -- ROKIT Healthcare, Inc., a regenerative medicine company focused on the development of novel regenerative therapeutic strategies using three-dimensional (3D) biofabricati...

Acarix Year-End Report 2018: Market dynamics favourable for CADScor®System, addressing the challenges of the global healthcare market

Malmö, February 20, 2019 Acarix Year-End Report 2018: Market dynamics favourable for CADScor®System, addressing the challenges of the global healthcare market "After six months at Acarix, I clearly see our market evolving and a growing opportunity for our products aimed at revolutionizing cardiac diagnostics. At congresses and scientific events, an increasing number of presentatio...

Tuesday 19th February 2019

Medtronic Receives FDA Breakthrough Designation for Developing Personalized Closed Loop Insulin Pump System for Diabetes Management

DUBLIN - February 19, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its Personalized Closed Loop (PCL) insulin pump system, currently in development. The PCL technology is designed to automate insulin delivery in a way that is real-time, per...

Vistin Pharma ASA : Fourth quarter 2018 financial results

Oslo, Norway, 19 February 2019 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the fourth quarter of 2018 in line with the business updates from the company on 4 and 8 January 2019. The revenues for the fourth quarter 2018 ended at NOK 40.1 million (Q4 2017: NOK 41.3 million). The loss from continuing operations ended at NOK -56.4 million (-6.8...

Monday 18th February 2019

Merger between Eckert & Ziegler BEBIG SA (BEBIG) and Eckert & Ziegler Strahlen - und Medizintechnik AG (EZAG) - Announcement of the effectiveness of the merger on 18 February 2019.

Press release  REGULATED INFORMATION Seneffe, Belgium, 18 February 2019. Effectiveness of the merger The merger between EZAG and BEBIG was approved by the shareholders of both merging companies, respectively on 20 December 2018 and 21 December 2018. The merger has been registered with the commercial register of EZAG, i.e. the Handelsregister Berlin-Charlottenburg on 18 February 20...

Aino Health AB (publ): Aino HealthManager deployed for global company

    18 February 2019  Aino Health's SaaS solution HealthManager has been deployed in two countries for a global company in customer service. It is a joint implementation project conducted by the client and Aino Health for 500 users. The implementation encompasses several client-tailored functionalities for automatic data transfer, adaptation to national legislation, vari...

Friday 15th February 2019

Aradigm Announces Plans for Reorganization Under Chapter 11 of the U.S. Bankruptcy Code

Aradigm Corporation (OTCQB: ARDM) (“Aradigm” or the “Company”) has filed for protection under Chapter 11 of the U.S. Bankruptcy Code in the Alameda County Court District to facilitate the sale of its assets. On February 11, 2019, Aradigm determined that without confirmation of funding from their primary investor and partner, the Company would not...

AHF Lauds Congress and the President for Boosting Global AIDS Funding

Funding bill will appropriate $5.72 billion for PEPFAR and $1.35 billion for the Global Fund to Fight AIDS, Tuberculosis and Malaria AIDS Healthcare Foundation (AHF) praised today the U.S. Congress and President Trump for adopting bipartisan appropriations l


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks